Williams-Sonoma director gets 137 deferred units

Williams-Sonoma director Anne A. Finucane reported receiving 137 deferred stock units on February 2, 2026.

Rhea-AI Filing Summary

Williams-Sonoma director Anne A. Finucane reported receiving 137 deferred stock units on February 2, 2026. Each deferred stock unit represents a contingent right to receive one share of Williams-Sonoma common stock. The units were granted at a price of $0 under the company’s 2001 Long-Term Incentive Plan.

The director elected to take these deferred stock units in lieu of the cash portion of annual retainers under the company’s Director Compensation Policy. The units are fully vested and are scheduled to be delivered in June 2027, at the end of the deferral period, with earlier delivery possible upon certain events.

Insider Trade Summary

Grant/Award: 137 shares

Grant/Award 1 txn

Insider Finucane Anne A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	137	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 137 contracts (Direct)

Footnotes (3)

1. F1. Each deferred stock unit represents a contingent right to receive one share of WSM common stock.
2. F2. The reporting person elected to receive these deferred stock units, which were granted under the Issuer's 2001 Long-Term Incentive Plan, pursuant to the Issuer's Director Compensation Policy (the "Policy"), in lieu of the cash portion of the annual retainers under the Policy.
3. F3. The deferred stock units are fully vested and will be delivered to the reporting person in June 2027, the end of the deferral period, subject to earlier delivery upon the occurrence of certain events.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Williams-Sonoma (WSM) disclose for Anne Finucane?

Williams-Sonoma disclosed that director Anne A. Finucane received 137 deferred stock units on February 2, 2026. These units were granted at $0 under the 2001 Long-Term Incentive Plan and taken instead of the cash portion of her annual director retainers.

How many Williams-Sonoma (WSM) deferred stock units did the director receive?

Anne A. Finucane received 137 deferred stock units of Williams-Sonoma. Each unit represents a contingent right to receive one share of common stock, so this award corresponds to 137 potential future shares, subject to the deferral and delivery terms disclosed.

What are Williams-Sonoma (WSM) deferred stock units as reported in this Form 4?

The deferred stock units are rights to receive shares of Williams-Sonoma common stock in the future. Each unit equals one share and is fully vested, with delivery scheduled for June 2027, or earlier if certain specified events occur under the plan.

Why did the Williams-Sonoma (WSM) director receive deferred stock units instead of cash?

The director elected to receive deferred stock units in lieu of the cash portion of annual retainers. This election was made under Williams-Sonoma’s Director Compensation Policy, with the units granted pursuant to the company’s 2001 Long-Term Incentive Plan.

When will the Williams-Sonoma (WSM) deferred stock units be delivered to the director?

The deferred stock units are scheduled to be delivered in June 2027. That date marks the end of the deferral period, although the units may be delivered earlier if certain events occur, as permitted under the plan’s terms.

Is the Williams-Sonoma (WSM) director’s deferred stock unit award fully vested?

Yes, the deferred stock units granted to Anne A. Finucane are fully vested. Although vesting is complete, the actual delivery of the underlying shares is deferred until June 2027, subject to possible earlier delivery upon specified events.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 06:16 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Finucane Anne A.

(Last) (First) (Middle)

3250 VAN NESS AVE.

(Street)

SAN FRANCISCO CA 94109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WILLIAMS SONOMA INC [ WSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/02/2026		A		137(2)		(3)	(3)	Common Stock	137	$0	137	D

Explanation of Responses:

1. Each deferred stock unit represents a contingent right to receive one share of WSM common stock.

2. The reporting person elected to receive these deferred stock units, which were granted under the Issuer's 2001 Long-Term Incentive Plan, pursuant to the Issuer's Director Compensation Policy (the "Policy"), in lieu of the cash portion of the annual retainers under the Policy.

3. The deferred stock units are fully vested and will be delivered to the reporting person in June 2027, the end of the deferral period, subject to earlier delivery upon the occurrence of certain events.

	/s/ David R. King, Attorney-in-Fact for Anne Finucane	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.